Cellectar Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cellectar Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cellectar Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.3M, a 41.6% decline year-over-year.
  • Cellectar Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$51.6M, a 52.4% decline year-over-year.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$39M, a 35.2% decline from 2022.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$28.8M, a 19.4% decline from 2021.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 57.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$51.6M -$13.3M -$3.91M -41.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 -$47.7M -$13.7M -$5.41M -65.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-29
Q1 2024 -$42.3M -$12M -$3.3M -37.9% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-10-29
Q4 2023 -$39M -$12.5M -$5.13M -69.1% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-10-29
Q3 2023 -$33.8M -$9.41M -$1.6M -20.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 -$32.2M -$8.29M -$858K -11.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-29
Q1 2023 -$31.4M -$8.71M -$2.57M -41.8% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-10-29
Q4 2022 -$28.8M -$7.42M -$1.5M -25.3% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-10-29
Q3 2022 -$27.3M -$7.82M -$2M -34.3% Jul 1, 2022 Sep 30, 2022 10-K/A 2024-10-29
Q2 2022 -$25.3M -$7.44M -$1.41M -23.3% Apr 1, 2022 Jun 30, 2022 10-K/A 2024-10-29
Q1 2022 -$23.9M -$6.14M +$219K +3.45% Jan 1, 2022 Mar 31, 2022 10-K/A 2024-10-29
Q4 2021 -$24.1M -$5.92M -$2.12M -55.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$22M -$5.82M -$1.91M -48.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$20.1M -$6.03M -$2.41M -66.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$17.7M -$6.36M -$2.4M -60.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$15.3M -$3.8M -$415K -12.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$14.9M -$3.91M +$53.9K +1.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$14.9M -$3.62M -$422K -13.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$14.5M -$3.96M -$329K -9.06% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$14.2M -$3.38M +$500K +12.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$14.7M -$3.96M -$876K -28.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$13.8M -$3.2M -$295K -10.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$13.5M -$3.63M -$176K -5.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$13.3M -$3.88M +$204K +4.98% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$13.5M -$3.09M +$396K +11.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$13.9M -$2.9M +$312K +9.69% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$14.2M -$3.45M -$641K -22.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$13.6M -$4.09M -$1.44M -54.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$12.2M -$3.48M -$1.02M -41.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$11.1M -$3.22M -$884K -37.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$10.3M -$2.81M -$812K -40.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$9.45M -$2.65M -$861K -48.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$8.59M -$2.47M -$375K -17.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$8.21M -$2.33M -$41.8K -1.82% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$8.17M -$2M +$587K +22.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$8.76M -$1.79M +$466K +20.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$9.22M -$2.09M +$181K +7.95% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$9.4M -$2.29M +$254K +10% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$9.66M -$2.59M +$232K +8.22% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$9.89M -$2.25M +$1.8M +44.5% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 -$11.7M -$2.27M +$637K +21.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$12.3M -$2.55M +$177K +6.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$12.5M -$2.82M -$107K -3.94% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$12.4M -$4.06M -$1.89M -87.5% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 -$10.5M -$2.91M -$856K -41.7% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-05-20
Q2 2013 -$9.65M -$2.72M -$511K -23.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$9.14M -$2.71M -$386K -16.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$8.75M -$2.16M -$145K -7.17% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$8.61M -$2.05M -$143K -7.48% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$8.47M -$2.21M +$42.9K +1.91% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$8.51M -$2.33M -$1.47M -173% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$7.04M -$2.02M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 -$1.91M -$1.3M -215% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$2.25M -$724K -47.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$854K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$607K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$1.53M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.